Evidence map›Paper›PMID 23514739›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2013

Antisense oligonucleotide treatment enhances the recovery of acute lung injury through IL-10-secreting M2-like macrophage-induced expansion of CD4+ regulatory T cells.

Zhongliang Guo, Zhenke Wen, Andong Qin, Ya Zhou, Zhenyuan Liao, Zhongmin Liu, Yongjie Liang, Tao Ren, Lin Xu

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Impairment of Fatty Acid Oxidation in Alveolar Epithelial Cells Mediates Acute Lung Injury.American journal of respiratory cell and molecular biology · 2019
    Article
  13. Review
  14. The Functional Mechanisms of miR-30b-5p in Acute Lung Injury in Children.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. MicroRNAs as biomarkers of acute lung injury.Annals of translational medicine · 2018
    Review
  20. MicroRNAs in injury and repair.Archives of toxicology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Zhongliang GuoDepartment of Respiratory Medicine, East Hospital, Tongji University School of Medicine, Shanghai, China.
Zhenke Wen
Andong Qin
Ya Zhou
Zhenyuan Liao
Zhongmin Liu
Yongjie Liang
Tao Ren
Lin Xu
Shanghai East Hospital · CNAffiliated Hospital of Zunyi Medical College · CNZunyi Medical University · CNShanghai Medical College of Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs (miRNAs) have been shown as an important regulator in the pathologies of acute lung injury (ALI). However, the potential effect of miRNA-based therapeutic studies in ALI remains poorly understood. We assessed the effect of antisense oligonucleotides (ASOs) against miR-155 on the development of ALI using a murine ALI model. We found that miR-155 ASO treatment could enhance the recovery of ALI as evidenced by accelerated body weight back, reduced level of bronchoalveolar lavage (BAL) protein and proinflammatory cytokines, and reduced number of BAL cells. Adoptive cell transfer assay in RAG1(-/-) mice showed that CD4(+)CD25(+) regulatory T cells (Tregs) mediated the enhanced recovery of ALI. Mechanistic evidence showed that enhanced expansion of Tregs in vivo, dominantly induced by IL-10-secreting M2-like macrophages, was critical for their elevated proportion in miR-155 ASO-treated ALI mice. Finally, we report that C/EBPβ, a target molecule of miR-155, was upregulated and associated with IL-10 secretion and M2-like phenotype of macrophages. These data provided a previously unknown mechanism for miRNA-based therapy against ALI, which could ultimately aid the understanding of recovery of ALI and the development of new therapeutic strategies against clinical inflammatory lung disease.

Indexed as

Acute Lung InjuryAnimalsCD4-Positive T-LymphocytesCell ProliferationInterleukin-10MacrophagesMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicMicroRNAsOligonucleotides, AntisenseRecovery of FunctionUp-RegulationIL10 protein, mouseInterleukin-10MicroRNAsMirn155 microRNA, mouseOligonucleotides, Antisense

Identifiers

PMID23514739
PMCPMC3619531
OpenAlexW2128866400

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.